Immune checkpoint inhibitors (ICI) in combination with chemotherapy as first-line (1L) treatment for non-small cell lung cancer (NSCLC): A pair-wise meta-analysis (MA)

  1. Afonso-Afonso, F.J.
  2. Gancedo, M. Amenedo
  3. Manrique, M.C. Areses
  4. Balea, B. Campos
  5. Rubio, J. Casal
  6. Fernández-Núñez, N.
  7. Perez, J.L. Firvida
  8. González, J. García
  9. Quintela, M. Lázaro
  10. León-Mateos, L.
  11. Ruíz-Bañobre, J.
  12. Parente, D. Pérez
  13. Crama, L.
  14. Gracia, P. Ruiz
  15. Couto, L. Santomé
Journal:
Annals of Oncology

ISSN: 0923-7534

Year of publication: 2019

Volume: 30

Pages: xi43

Type: Article

DOI: 10.1093/ANNONC/MDZ451.025 GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Annals of Oncology